January 29, 2024 – Case Study

Reduces wastage

Implementation of INTERCEPT Fibrinogen Complex (IFC) at Stanford Hospital – Improves Wait Times and Reduces Wastage

January 10, 2024 – EAST 2024 Presentation

Fibrinogen supplementation

Fibrinogen Supplementation in Hemorrhagic Shock: Role of INTERCEPT Fibrinogen Complex

October 14-17, 2023 – AABB 2023 Posters

AABB Posters

Improved Turnaround Times and Reduced Wastage with Implementation of INTERCEPT Fibrinogen Complex (Four Independent Posters)

October 16, 2023 – AABB 2023 Presentation

Pathogen reduction

Expanding the Use of Pathogen Reduction for Improved Blood Safety and Availability

May 8, 2023 – SCA 2023 Presentation

Cardiac surgery

INTERCEPT® Fibrinogen Complex in Cardiac Surgery: Experience at Stanford Hospital

February 2, 2023 – Case Study

Pediatric setting

Implementing the Use of INTERCEPT Fibrinogen Complex (IFC) in the Pediatric Setting – Valley Children’s Hospital

January 19, 2023 – EAST 2023 Presentation

Initial trauma

INTERCEPT Fibrinogen Complex: Initial Trauma Experience at UF Health

November 30, 2022 – AABB Webinar

Stanford implementation

INTERCEPT Fibrinogen Complex: Implementation and Initial Experience at Stanford Hospital

October 7, 2022 – Case Study

Massive Transfusion Protocol (MTP)

Assessing Impact of INTERCEPT Fibrinogen Complex (IFC) on Wastage and Massive Transfusion Protocols (MTPs) – UF Health

September 15, 2022 – SABM 2022 Presentation

IFC pediatric

Implementing the Use of INTERCEPT Fibrinogen Complex (IFC) in the Pediatric Setting

April 28, 2022 – AABB Webinar

IFC UF Health

UF Health Shands’ Experience to Date with INTERCEPT Fibrinogen Complex (IFC)

April 28, 2022 – AABB Webinar

Postpartum fibrinogen

Postpartum Hemorrhage and Target-Directed MTP Lessons Learned about Fibrinogen Replacement

March 16, 2022 – Legislative Update

Cerus Encouraged by the NDAA FY2022 Consideration of PR Resuscitative Products for Clinical Guidelines to Treat Obstetric Hemorrhage

Sept 20, 2021 – Press Release

Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021

Aug 20, 2021 – Announcement

First Patient Treated with
INTERCEPT Fibrinogen Complex

Aug 10, 2021 – Press Release

Cerus Corporation Announces CMS Issuance of P-Codes for Hospital Outpatient Billing of INTERCEPT-Based Therapeutic Products

Aug 3, 2021 – Press Release

Improves wait times

Cerus Corporation Announces CMS Has Granted New Technology Add-On Payment for INTERCEPT Fibrinogen Complex

Nov 30, 2020 – Press Release

FDA approval

Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Cryoprecipitation

Oct 31, 2020 – Press Release


Cerus Receives FDA Breakthrough Device Designation for Pathogen-Reduced Cryoprecipitate